Next Article in Journal
Introducing a Novel Personalized Microbiome-Based Treatment for Inflammatory Bowel Disease: Results from NostraBiome’s Internal Validation Study
Next Article in Special Issue
Engineered Expression of Hepatocyte Growth Factor Activator Inhibitor-1 (HAI-1) Reduces the Growth of Bladder Cancer Cells
Previous Article in Journal
Synthesis and Evaluation of Isosteviol Derivatives: Promising Anticancer Therapies for Colon Cancer
Previous Article in Special Issue
Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer
 
 
Review

Article Versions Notes

Biomedicines 2025, 13(4), 794; https://doi.org/10.3390/biomedicines13040794
Action Date Notes Link
article xml file uploaded 26 March 2025 08:58 CET Original file -
article xml uploaded. 26 March 2025 08:58 CET Update https://www.mdpi.com/2227-9059/13/4/794/xml
article pdf uploaded. 26 March 2025 08:58 CET Version of Record https://www.mdpi.com/2227-9059/13/4/794/pdf
article html file updated 26 March 2025 09:00 CET Original file https://www.mdpi.com/2227-9059/13/4/794/html
Back to TopTop